325 related articles for article (PubMed ID: 16816556)
41. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia.
Choun K; Thai S; Pe R; Lorent N; Lynen L; van Griensven J
Trans R Soc Trop Med Hyg; 2013 Apr; 107(4):235-42. PubMed ID: 23324313
[TBL] [Abstract][Full Text] [Related]
42. Anti-PGL-Tb1 responses as an indicator of the immune restoration syndrome in HIV-TB patients.
Simonney N; Dewulf G; Herrmann JL; Gutierrez MC; Vicaut E; Boutron C; Leportier M; Lafaurie M; Abgrall S; Sereni D; Autran B; Carcelain G; Bourgarit A; Lagrange PH
Tuberculosis (Edinb); 2008 Sep; 88(5):453-61. PubMed ID: 18495539
[TBL] [Abstract][Full Text] [Related]
43. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
44. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
45. Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes?
Harries AD; Chimzizi RB; Nyirenda TE; van Gorkom J; Salaniponi FM
Int J Tuberc Lung Dis; 2003 Jul; 7(7):616-22. PubMed ID: 12870681
[TBL] [Abstract][Full Text] [Related]
46. Screening HIV-infected persons for tuberculosis--Cambodia, January 2004-February 2005.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(46):1177-80. PubMed ID: 16304553
[TBL] [Abstract][Full Text] [Related]
47. National scale-up of HIV testing and provision of HIV care to tuberculosis patients in Kenya.
Chakaya JM; Mansoer JR; Scano F; Wambua N; L'Herminez R; Odhiambo J; Mohamed I; Kangangi J; Ombeka V; Akeche G; Adala S; Gitau S; Maina J; Kibias S; Langat B; Abdille N; Wako I; Kimuu P; Sitienei J
Int J Tuberc Lung Dis; 2008 Apr; 12(4):424-9. PubMed ID: 18371269
[TBL] [Abstract][Full Text] [Related]
48. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
Paton NI; Sangeetha S; Earnest A; Bellamy R
HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
[TBL] [Abstract][Full Text] [Related]
49. The epidemiology of HIV-associated tuberculosis in rural Cambodia.
Cain KP; Kanara N; Laserson KF; Vannarith C; Sameourn K; Samnang K; Qualls ML; Wells CD; Varma JK
Int J Tuberc Lung Dis; 2007 Sep; 11(9):1008-13. PubMed ID: 17705980
[TBL] [Abstract][Full Text] [Related]
50. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
51. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia.
Huruy K; Mulu A; Mengistu G; Shewa-Amare A; Akalu A; Kassu A; Andargie G; Elias D; Torben W
Jpn J Infect Dis; 2008 May; 61(3):205-9. PubMed ID: 18503170
[TBL] [Abstract][Full Text] [Related]
52. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
Dowdy DW; Chaisson RE; Moulton LH; Dorman SE
AIDS; 2006 Mar; 20(5):751-62. PubMed ID: 16514306
[TBL] [Abstract][Full Text] [Related]
53. Effect of highly active antiretroviral therapy on incidence of early syphilis in HIV-infected patients.
Park WB; Jang HC; Kim SH; Kim HB; Kim NJ; Oh MD; Choe KW
Sex Transm Dis; 2008 Mar; 35(3):304-6. PubMed ID: 18157070
[TBL] [Abstract][Full Text] [Related]
54. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
55. [Dermatologic manifestations associated with immune reconstitution syndrome in HIV+ patients starting HAART: a retrospective study in French Guiana].
Sarazin E; Nacher M; Toure Y; Clyti E; El Guedj M; Aznar C; Vaz T; Sainte-Marie D; Sobesky M; Carme B; Couppié P
Bull Soc Pathol Exot; 2005 Sep; 98(3):187-92. PubMed ID: 16267958
[TBL] [Abstract][Full Text] [Related]
56. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa.
Moh R; Danel C; Messou E; Ouassa T; Gabillard D; Anzian A; Abo Y; Salamon R; Bissagnene E; Seyler C; Eholié S; Anglaret X
AIDS; 2007 Nov; 21(18):2483-91. PubMed ID: 18025885
[TBL] [Abstract][Full Text] [Related]
57. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
58. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
[TBL] [Abstract][Full Text] [Related]
59. Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.
Mussini C; Manzardo C; Johnson M; Monforte Ad; Uberti-Foppa C; Antinori A; Gill MJ; Sighinolfi L; Borghi V; Lazzarin A; Miró JM; Sabin C;
AIDS; 2008 Nov; 22(18):2461-9. PubMed ID: 19005269
[TBL] [Abstract][Full Text] [Related]
60. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
